1.3700
-0.0800
(-5.52%)
At close: January 10 at 4:00:00 PM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-16,812.0000
-16,260.0000
-12,657.0000
-23,584.0000
-15,311.0000
Investing Cash Flow
--
--
--
10,050.0000
5,013.0000
Financing Cash Flow
21,603.0000
--
24,760.0000
3,878.0000
18,256.0000
End Cash Position
30,445.0000
16,982.0000
33,596.0000
20,535.0000
30,375.0000
Issuance of Capital Stock
19,714.0000
--
24,760.0000
3,509.0000
11,411.0000
Repayment of Debt
--
--
--
-37.0000
-39.0000
Free Cash Flow
-16,845.0000
-16,260.0000
-12,657.0000
-23,584.0000
-15,311.0000
3/31/2021 - 3/8/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MSCL.TO Satellos Bioscience Inc.
0.8500
+1.19%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
APS.TO Aptose Biosciences Inc.
0.3150
+1.61%
TH.TO Theratechnologies Inc.
2.6900
-7.88%
ARCH.V Arch Biopartners Inc.
1.9500
+1.04%
MSCLF Satellos Bioscience Inc.
0.5990
0.00%
DRUG.CN Bright Minds Biosciences Inc.
56.00
-3.25%
SVA.TO Sernova Corp.
0.2250
0.00%
NGEN.V NervGen Pharma Corp.
3.0900
+3.69%